$12.85
+0.42 (+3.34%)
Open$12.52
Previous Close$12.43
Day High$13.67
Day Low$12.27
52W High$43.53
52W Low$18.98
Volume—
Avg Volume790.0K
Market Cap20.47M
P/E Ratio22.28
EPS$1.68
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 10.61M | 10.68M | 9.55M |
| Net Income | 789.2K | 807.9K | 770.6K |
| Profit Margin | 7.4% | 7.6% | 8.1% |
| EBITDA | 1.40M | 1.47M | 1.23M |
| Free Cash Flow | 547.8K | 770.2K | 737.4K |
| Rev Growth | -2.0% | +19.5% | +10.5% |
| Debt/Equity | 0.36 | 0.38 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |